A study on the symptoms of Rhus toxicodendron in cases of lower backache using Synthesis Repertory

Representation Reliability of Rhus toxicodendron in Rubrics related to Sciatica in Synthesis Repertory - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/069593

Enrollment

Registered

2024-06-27

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M543- Sciatica

Interventions

Intervention1: Rhus toxicodendron 30 C: Rhus toxicodendron 30 C will be prescribed fort nightly for a period of 3 months Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Patients with cases of Sciatica with Rhus Toxicodendron as the indicated medicine. Patients with positive SLR test Intervertebral Disc Prolapse or protrusion lumbar Disc Prolapses or Protrusion Lumbar Disc Herniation Spondylolisthesis

Exclusion criteria

Exclusion criteria: Patients below 30 years of age and above 75 years of age. Patients requiring emergency medical treatment. Patients undergoing treatment for severe systemic illness or surgical complications

Design outcomes

Primary

Measure	Time frame
Reliability and applicability of rubrics related to the medicine Rhus toxicodendron for cases of sciatica will be verified. Timepoint: 3 Months	—

Secondary

Measure	Time frame
The clinical course of sciatica during the treatment with Rhus toxicodendron can observed. The time taken for response after the administration of Rhus toxicodendron can be assessed.Timepoint: 3 Months	—

Countries

India

Contacts

Public ContactDr A S Suman Sankar

Sarada Krishna Homoeopathic Medical College

dissert02@gmail.com9443500675

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026